209 related articles for article (PubMed ID: 29880288)
1. Usefulness of a Simple Algorithm to Identify Hypertensive Patients Who Benefit from Intensive Blood Pressure Lowering.
Wang S; Khera R; Das SR; Vigen R; Wang T; Luo X; Lu R; Zhan X; Xiao G; Vongpatanasin W; Xie Y
Am J Cardiol; 2018 Jul; 122(2):248-254. PubMed ID: 29880288
[TBL] [Abstract][Full Text] [Related]
2. Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials.
Basu S; Sussman JB; Rigdon J; Steimle L; Denton BT; Hayward RA
PLoS Med; 2017 Oct; 14(10):e1002410. PubMed ID: 29040268
[TBL] [Abstract][Full Text] [Related]
3. Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT.
Beddhu S; Chertow GM; Greene T; Whelton PK; Ambrosius WT; Cheung AK; Cutler J; Fine L; Boucher R; Wei G; Zhang C; Kramer H; Bress AP; Kimmel PL; Oparil S; Lewis CE; Rahman M; Cushman WC
J Am Heart Assoc; 2018 Sep; 7(18):e009326. PubMed ID: 30371182
[TBL] [Abstract][Full Text] [Related]
4. Personalizing the Intensity of Blood Pressure Control: Modeling the Heterogeneity of Risks and Benefits From SPRINT (Systolic Blood Pressure Intervention Trial).
Patel KK; Arnold SV; Chan PS; Tang Y; Pokharel Y; Jones PG; Spertus JA
Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28373269
[TBL] [Abstract][Full Text] [Related]
5. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
[TBL] [Abstract][Full Text] [Related]
6. Individualising intensive systolic blood pressure reduction in hypertension using computational trial phenomaps and machine learning: a post-hoc analysis of randomised clinical trials.
Oikonomou EK; Spatz ES; Suchard MA; Khera R
Lancet Digit Health; 2022 Nov; 4(11):e796-e805. PubMed ID: 36307193
[TBL] [Abstract][Full Text] [Related]
7. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP.
Buckley LF; Dixon DL; Wohlford GF; Wijesinghe DS; Baker WL; Van Tassell BW
Diabetes Care; 2017 Dec; 40(12):1733-1738. PubMed ID: 28947569
[TBL] [Abstract][Full Text] [Related]
8. A data-zone scoring system to assess the generalizability of clinical trial results to individual patients.
Laffin LJ; Besser SA; Alenghat FJ
Eur J Prev Cardiol; 2019 Apr; 26(6):569-575. PubMed ID: 30477321
[TBL] [Abstract][Full Text] [Related]
9. Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials.
Brouwer TF; Vehmeijer JT; Kalkman DN; Berger WR; van den Born BH; Peters RJ; Knops RE
Diabetes Care; 2018 Jun; 41(6):1142-1148. PubMed ID: 29212825
[TBL] [Abstract][Full Text] [Related]
10. Role of Diuretics in Cardiovascular Events and Mortality in Systolic Blood Pressure Intervention Trial: A Post Hoc Analysis.
Bansal S; Boucher R; Shen J; Wei G; Chertow GM; Whelton PK; Cushman WC; Cheung AK; Beddhu S;
Clin J Am Soc Nephrol; 2024 May; 19(5):620-627. PubMed ID: 38262377
[TBL] [Abstract][Full Text] [Related]
11. Effect of intensive blood pressure lowering on cardiovascular outcomes based on cardiovascular risk: A secondary analysis of the SPRINT trial.
Attar A; Sayadi M; Jannati M
Eur J Prev Cardiol; 2019 Feb; 26(3):238-245. PubMed ID: 30256671
[TBL] [Abstract][Full Text] [Related]
12. Effects of Intensive Systolic Blood Pressure Lowering on End-Stage Kidney Disease and Kidney Function Decline in Adults With Type 2 Diabetes Mellitus and Cardiovascular Risk Factors: A Post Hoc Analysis of ACCORD-BP and SPRINT.
Tawfik YMK; Van Tassell BW; Dixon DL; Baker WL; Fanikos J; Buckley LF
Diabetes Care; 2023 Apr; 46(4):868-873. PubMed ID: 36787937
[TBL] [Abstract][Full Text] [Related]
13. Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria:
Chang AR; Kramer H; Wei G; Boucher R; Grams ME; Berlowitz D; Bhatt U; Cohen DL; Drawz P; Punzi H; Freedman BI; Haley W; Hawfield A; Horwitz E; McLouth C; Morisky D; Papademetriou V; Rocco MV; Wall B; Weiner DE; Zias A; Beddhu S;
Clin J Am Soc Nephrol; 2020 Aug; 15(8):1121-1128. PubMed ID: 32669306
[TBL] [Abstract][Full Text] [Related]
14. Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).
Bress AP; Kramer H; Khatib R; Beddhu S; Cheung AK; Hess R; Bansal VK; Cao G; Yee J; Moran AE; Durazo-Arvizu R; Muntner P; Cooper RS
Circulation; 2017 Apr; 135(17):1617-1628. PubMed ID: 28193605
[TBL] [Abstract][Full Text] [Related]
15. Effects of Intensive Blood Pressure Control in Patients with Evident Cardiovascular Disease: An Investigation Using the SPRINT Study Data.
Vlachopoulos C; Terentes-Printzios D; Aznaouridis K; Ioakeimidis N; Xaplanteris P; Lazaros G; Tousoulis D
Curr Vasc Pharmacol; 2019; 17(3):298-306. PubMed ID: 29512468
[TBL] [Abstract][Full Text] [Related]
16. More Versus Less Blood Pressure Lowering: An Update.
Atkins ER; Rodgers A
Clin Ther; 2016 Oct; 38(10):2135-2141. PubMed ID: 27633256
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Hypertension: Which Goal for Which Patient?
Jarraya F
Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961
[TBL] [Abstract][Full Text] [Related]
18. Effects of intensive blood pressure lowering in patients with diabetes: A pooled analysis of the STEP and ACCORD-BP randomized trials.
Yang R; Bai J; Fang Z; Wang Y; Feng Y; Liu Y; Chi H; Deng Y; Song Q; Cai J
Diabetes Obes Metab; 2023 Mar; 25(3):796-804. PubMed ID: 36433919
[TBL] [Abstract][Full Text] [Related]
19. Clinical Value of Predicting Individual Treatment Effects for Intensive Blood Pressure Therapy.
Duan T; Rajpurkar P; Laird D; Ng AY; Basu S
Circ Cardiovasc Qual Outcomes; 2019 Mar; 12(3):e005010. PubMed ID: 30857410
[TBL] [Abstract][Full Text] [Related]
20. Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results.
Huang C; Dhruva SS; Coppi AC; Warner F; Li SX; Lin H; Nasir K; Krumholz HM
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29133522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
